-
XIX International AIDS Conference satellite session on using PrEP to prevent HIV sponsored by amfAR, AVAC, The Fenway Institute, the MSM Global Forum, the Justice Resource Institute, the National...
-
Sean Cahill and Kenneth Mayer, MD of The Fenway Institute discuss the U.S. Food and Drug Administration’s decision to approve the drug tenofovir disoproxil fumarate/emtricitabine (brand name Truvada) for use...
-
Last night, the U.S. Food and Drug Administration’s (FDA) Antiviral Drugs Advisory Committee recommended that emtricitabine/tenofovir disoproxil fumarate (FTC-TDF, marketed by Gilead Pharmaceuticals as Truvada) be indicated for use in...
-
Today, the U.S. Food and Drug Administration (FDA) is reviewing a supplemental new drug application for emtricitabine/tenofovir disoproxil fumarate (FTC-TDF) to reduce the risk of acquiring HIV in men and...
-
Analysis examines biomedical prevention technology to be reviewed by U.S. Food and Drug Administration by June 15, 2012
Pre-exposure chemoprophylaxis (PrEP)—taking antiretroviral medications to prevent HIV transmission—could be a “game...
